Drug resistance associated with altered DNA topoisomerase II.
Beck
W T
WT
Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, TN 38101.
Danks
M K
MK
Wolverton
J S
JS
Kim
R
R
Chen
M
M
D000970:Antineoplastic Agents / Q000494:pharmacology; D004250:DNA Topoisomerases, Type II / Q000235:genetics* / Q000378:metabolism; D004351:Drug Resistance / Q000235:genetics / Q000502:physiology; D006801:Humans; D010641:Phenotype; D011110:Polymorphism, Genetic; D059005:Topoisomerase II Inhibitors; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000201:enzymology
D000970:Antineoplastic Agents; D059005:Topoisomerase II Inhibitors; D004250:DNA Topoisomerases, Type II